U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
NCT07325578
Bone Diseases, Bone Diseases, Metabolic
San Diego, California, United States
View Trial DetailsNCT Number: NCT02958020
This is a multicenter cohort study on osteoporosis in nine cities of China which locate in the east, south, north, west, middle of China. At least 3000 middle-aged and elderly permanent residents (women aged from 45 to 79, and men aged from 50 to 79) in every city will be enrolled. Residents with severe mental diseases, physical diseases or acute infectious diseases who could not cooperate with the survey as well as lactating or pregnant women were excluded. All the enrolled residents who signed informed consent will finish questionnaire including demographic characteristics, history of smoking, alcohol drinking, falls and fracture, family genetic history, chronic diseases and medicine,diary and physical practice,stool and urine status. Osteoporosis risk, health status, constitution of traditional Chinese medicine (TCM),symptoms of kidney yang deficiency in TCM,living environment,sweating status will be evaluated. Fasting blood glucose test and other blood tests for liver and kidney function,bone metabolism,vitamins,vitamin D metabolism and transportation as well as calcium and phosphate metabolism, will be performed. Bone mineral density and physical examinations (height, weight, waist circumference, hip circumference,grip,sit-to-stand test, tongue coating and pulse) will also be performed at enrollment and every two years after enrollment. DNA of blood cells will be preserved for specific study such as SNP analyses.Tongue coating and feces will be preserved for microflora analyses.
Interested in participating?
Request Info45 year–79 year
All sexes
Observational
Shenzhen Pingle Orthopedic Hospital, Shenzhen, Guangdong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
lumbar (L1-4 as well as total) and hip bone mineral density will be recorded by dual energy X-ray absorptiometry.
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
information about fracture including cause, time, skeletal site and therapy during the follow-up period will be collected through fracture questionnaire
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Time frame: at enrollment, and 2, 4, 6, 8 and 10 years after enrollment
Contact information is provided by the study sponsor or research team.
Shanghai University of Traditional Chinese Medicine
Other
Multicenter Cohort Study on Osteoporosis in the Middle-aged and Elderly People in Shanghai, China
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07325578
Bone Diseases, Bone Diseases, Metabolic
San Diego, California, United States
View Trial DetailsNCT06059222
Bone Diseases, Bone Diseases, Metabolic
Aarhus, Denmark
View Trial DetailsNCT07677033
Atrophy, Bone Diseases
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07677072
Bone Diseases, Bone Diseases, Metabolic
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial Details